Management tracks: Evox names Moses chairman; Kapeller joins GV

Exosome therapy company Evox Therapeutics Ltd. (Oxford, U.K.) appointed Edwin Moses as chairman. This month, the former Ablynx N.V. CEO was also appointed chairman of Virion Biotherapeutics Ltd. (London, U.K.) and Achilles Therapeutics Ltd. (Stevenage, U.K.).

GV named Rosana Kapeller entrepreneur-in-residence and David Reshef as venture partner on the company's life science team. Kapeller resigned in March as CSO from computational chemistry company Nimbus Therapeutics LLC (Cambridge, Mass.). Reshef has a Ph.D. in computer science from the Massachusetts Institute of Technology...